A Study to Find out Correlation of Thyroid Hormone among COPD patients: A Hospital Based Study
DOI:
https://doi.org/10.21276/3qt1rv14Keywords:
Chronic Obstructive Pulmonary Disease, Hormone, ThyroidAbstract
Background: Chronic obstructive pulmonary disease (COPD) is a growing cause of morbidity and mortality worldwide Abnormalities in thyroid hormone regulation are encountered frequently in nonthyroidal diseases. Hence; the present study was undertaken for assessing the correlation of thyroid hormone among COPD patients.
Materials & Methods: In the present study, a total of 200 patients were enrolled, which were diagnosed to be suffering from COPD. Complete medical history and family history of all the subjects was also obtained. Blood samples were taken from all the patients and were sent to laboratory for assessment of thyroid profile. COPD patients were divided into four stages as follows: Stage 1- Mild, Stage 2- Moderate, Stage 3- Severe, and Stage 4- Very Severe. All the results were recorded in Microsoft excel sheet and were analyzed by SPSS software.
Results: Thyroid dysfunction was found to be present in 47 patients (23.5 percent of patients). Among 200 COPD patients, 52, 45, 50 and 53 patients were of stage 1, 2, 3 and 4 respectively. Among 53 patients of stage 4, thyroid dysfunction was found to be present in 33.96 percent of the patients. Among 50 patients of stage 3, thyroid dysfunction was found to be present in 24 percent of the patients. Among 45 patients of stage 2, thyroid dysfunction was found to be present in 20 percent of the patients. Among 52 patients of stage 1, thyroid dysfunction was found to be present in 15.38 percent of the patients.
Conclusion: Thyroid dysfunction is a serious health problem affecting more commonly in patients with stage 3 and stage 4 COPD.
Downloads
References
Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management, and Prevention of COPD (revised 2013).
Martinez FJ, Bermudez-Gomez M, Celli BR. Hypothyroidism. A reversible cause of diaphragmatic dysfunction. Chest. 1989;96:1059–63.
Siafakas NM, Salesiotou V, Filaditaki V, Tzanakis N, Thalassinos N, Bouros D, et al. Respiratory muscle strength in hypothyroidism. Chest. 1992;102:189–94.
Laghi F, Adiguzel N, Tobin MJ. Endocrinological derangements in COPD. Eur Respir J. 2009;34:975–96.
Chaudhary SC, Ahmad T, Usman K, et al. Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India. J Family Med Prim Care. 2018;7(3):584–588.
Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–268.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2(5147):257–266.
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555.
Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
Sarinc Ulasli S, Bozbas SS, Ozen ZE, Ozyurek BA, Ulubay G. Effect of thyroid function on COPD exacerbation frequency: A preliminary study. Multidiscip Respir Med. 2013;8:64.
Aras G, Kanmaz D, Purisa S, Kadakal F, Yentürk E, Atabey F, et al. Are thyroid functions changing in patients with exacerbated COPD? Thyroid functions in exacerbated COPD. JAREM. 2014;1:18–24.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
